Clayton Robertson
Investor Relations Contact at IMMUNOCORE HOLDINGS PLC
Profile
Clayton Robertson is currently the Head-Investor Relations at Immunocore Holdings Plc.
Previously, he worked as the Director-Investor Relations at Actinium Pharmaceuticals, Inc. from 2020 to 2021, Director-Investor Relations at PureTech Health Plc in 2020, and Investor Relations Contact at Achillion Pharmaceuticals, Inc. from 2019 to 2020.
He also worked as an Analyst at Trout Capital LLC.
Mr. Robertson completed his undergraduate degree at the University of Pennsylvania.
Clayton Robertson active positions
Companies | Position | Start |
---|---|---|
IMMUNOCORE HOLDINGS PLC | Investor Relations Contact | 01/02/2021 |
Former positions of Clayton Robertson
Companies | Position | End |
---|---|---|
ACTINIUM PHARMACEUTICALS, INC. | Investor Relations Contact | 01/02/2021 |
PURETECH HEALTH PLC | Investor Relations Contact | 01/08/2020 |
ACHILLION PHARMACEUTICALS, INC. | Investor Relations Contact | 01/05/2020 |
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco. | Analyst-Equity | - |
Training of Clayton Robertson
University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
IMMUNOCORE HOLDINGS PLC | Health Technology |
ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
PURETECH HEALTH PLC | Health Technology |
Private companies | 2 |
---|---|
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco. | Finance |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Stock Market
- Insiders
- Clayton Robertson